Back to VE Van Eck Associates Corp
REGN
Showing 8 of 28 quarters
Position history for VEVan Eck Associates Corp's holdings in Regeneron Pharmaceuticals, Inc.
Yes. Van Eck Associates holds 71,402 shares of REGN (Regeneron Pharmaceuticals), worth $54.1M, as of its Q3 2026 13F filing. It increased the position by 6,070 shares (+9.3%) from Q2 2026. Van Eck Associates has listed REGN in each of its last 28 quarterly 13F filings.
Current Value
$54.1M
Current Shares
71,402
Total Value Change
+$12.4M
Total Shares Change
+12,869
Quarter-by-Quarter History